首页 › 基金 › Samsara BioCapital, LLC › AGMB
Samsara BioCapital, LLC 对 AGMB 的持仓历史
AGOMAB THERAPEUTICS NV · 医疗保健
Samsara BioCapital, LLC 在 Q3 2026 的 13F 申报中披露持有 AGMB(AGOMAB THERAPEUTICS NV)594,749 股,市值约 US$6.6M,约占其申报组合的 0.63%,在其申报持仓中市值排名第 20 位。 Samsara BioCapital, LLC 最近 3 个申报季度中有 3 个季度披露了 AGMB 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Samsara BioCapital, LLC 对 AGMB 的持仓演变
Samsara BioCapital, LLC 于 Q1 2026 首次披露 AGMB 持仓:600,000 股(约 US$6.3M)。 该持仓在 Q2 2026 达到峰值 600,000 股,市值约 US$7.8M。 在 3 次申报中,Samsara BioCapital, LLC 0 次增持、1 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 594,749 股、市值约 US$6.6M,环比减持 -5,251 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 600.00K | $6.29M | 新进 |
| Q2 2026 | 600.00K | $7.79M | 持有 |
| Q3 2026 | 594.75K | $6.60M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 AGMB 与 13F 数据
AGMB(AGOMAB THERAPEUTICS NV)属于医疗保健行业。我们追踪的基金中还有 38 只申报持有 AGMB,申报仓位最大的包括:EQT Fund Management S.a r.l. (US$57.1M), Sanofi (US$30.9M), Cormorant Asset Management, LP (US$27.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 AGMB 的基金
- EQT Fund Management S.a r.l. 5.14M 股 · $57.08M · Q3 2026
- Sanofi 2.78M 股 · $30.89M · Q3 2026
- Cormorant Asset Management, LP 2.47M 股 · $27.37M · Q3 2026
- PFIZER INC 2.15M 股 · $22.61M · Q3 2026
- TCG Crossover Management, LLC 1.82M 股 · $20.21M · Q3 2026
- Nantahala Capital Management, LLC 1.75M 股 · $19.40M · Q3 2026
- Redmile Group, LLC 1.74M 股 · $19.32M · Q3 2026
- Casdin 资本 1.55M 股 · $17.20M · Q3 2026
- Andera Partners 1.54M 股 · $17.08M · Q3 2026
更多关于 Samsara BioCapital, LLC
常见问题
How long has Samsara BioCapital, LLC held AGMB?
Samsara BioCapital, LLC has disclosed AGMB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Samsara BioCapital, LLC's current position in AGMB?
As of Q3 2026, Samsara BioCapital, LLC holds 594.75K shares of AGMB (AGOMAB THERAPEUTICS NV), valued at $6.60M, representing 0.63% of its reported portfolio and ranking #20.
Has Samsara BioCapital, LLC been buying or selling AGMB?
In the latest 13F filing (Q3 2026), Samsara BioCapital, LLC reduced its position in AGMB. The position peaked in Q2 2026 at 600.00K shares.
Which other funds hold AGMB?
Other major institutional holders of AGMB include EQT Fund Management S.a r.l., Sanofi, Cormorant Asset Management, LP, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.